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Abstract
Modifications of RNA, collectively termed as the epitranscriptome, are widespread, evolutionarily conserved and
contribute to gene regulation and protein diversity in healthy and disease states. There are >160 RNA modifications
described, greatly exceeding the number of modifications to DNA. Of these, adenosine-to-inosine (A-to-I) RNA editing
is one of the most common. There are tens of thousands of A-to-I editing sites in mouse, and millions in humans.
Upon translation or sequencing an inosine base is decoded as guanosine, leading to A-to-G mismatches between the
RNA and DNA. Inosine has different base pairing properties to adenosine and as a result editing not only alters the
RNA code but can also change the RNA structure. In mammals A-to-I editing is performed by ADAR1 and ADAR2. A
feature of murine loss of function ADAR1 alleles is cell death and a failure to survive embryogenesis. Adar1−/− and
editing deficient (Adar1E861A/E861A) mice die between E11.75–13.5 of failed hematopoiesis. Strikingly this phenotype is
rescued by the deletion of the cytosolic dsRNA sensor MDA5 or its downstream adaptor MAVS, a mechanism
conserved in human and mouse. Current literature indicates that the loss of ADAR1 leads to cell death via apoptosis,
yet this has not been genetically established. We report that blockade of the intrinsic (mitochondrial) apoptosis
pathway, through the loss of both BAK and BAX, does not rescue or modify the cellular phenotype of the fetal liver or
extend the lifespan of ADAR1 editing deficient embryos. We had anticipated that the loss of BAK and BAX would
rescue, or at least significantly extend, the gestational viability of Adar1E861A/E861A embryos. However, the triple mutant
Adar1E861A/E861A Bak−/− Bax−/− embryos that were recovered at E13.5 were indistinguishable from the Adar1E861A/E861A
embryos with BAK and BAX. The results indicate that cell death processes not requiring the intrinsic apoptosis pathway
are triggered by MDA5 following the loss of ADAR1.
Adenosine-to-inosine (A-to-I) RNA editing is one of the
most prevalent post-transcriptional modifications of
RNA. There are tens of thousands of A-to-I editing sites
in mouse, and millions in humans. Upon translation or
sequencing an inosine base is decoded as guanosine,
leading to A-to-G mismatches between the RNA and
genomic DNA. Inosine has different thermodynamic base
pairing properties to adenosine and as a result A-to-I
editing not only alters the RNA code but can lead to
changes in RNA structure1. Editing frequencies vary from
<1 to 100% for any given site, and dynamic differences are
observed for the same site across cell types, development,
and aging. A-to-I editing in an exonic region can change
the protein coding potential of a transcript. However,
most editing occurs in non-coding regions where it can
alter splicing, miRNA binding, miRNA sequences them-
selves, formation of other RNA species such as circular
RNAs, secondary structure, and immunogenicity. The
largest proportion of mammalian editing occurs in repe-
titive elements such as SINEs and LINEs, including Alu
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elements, which can form structured long double-
stranded RNAs (dsRNA)1.
In mammals, A-to-I editing is catalyzed by ADAR1 and
ADAR2. ADAR1 is broadly expressed across cell types
and tissues, while ADAR2 has a more restricted expres-
sion pattern with highest levels in the brain. In mice,
deletion of ADAR2 causes post-natal lethality due to the
development of seizures. This phenotype was rescued by
homozygosity for a single residue A-to-G replacement in
the genomic DNA of the A-to-I edited Q/R codon of
Gria2, which mimics constitutive recoding at this site2. In
contrast, Adar1−/− or editing-deficient (Adar1E861A/E861A)
mice die in utero at E11.75–E12.5 (refs. 3,4) and E13.5
(ref. 5), respectively. Adar1−/− animals die from a failure
of fetal liver hematopoiesis, primarily erythropoiesis, as
evidenced by the fact that the phenotype is reproduced in
mice with an erythroid lineage-restricted deletion of
ADAR1 (ref. 6). ADAR1 null or editing-deficient animals
can be rescued by concurrent loss of the cytosolic dsRNA
sensor MDA5 (encoded by Ifih1) or its downstream
effector MAVS5,7,8. This body of work, complemented
and confirmed by analysis of human ADAR1-deficient
cells, has established that the essential species-conserved
function of ADAR1 editing is to attenuate the immuno-
genic potential of endogenous dsRNA and prevent an
MDA5-mediated innate immune response to self-
dsRNA5,7–9. What remains unclear are the mechanisms
that cause ADAR1-editing-deficient cells to die. Strik-
ingly, the death of ADAR1-deficient mouse embryos or
ADAR1-deficient human cells can be suppressed by loss
of MDA5 or MAVS, indicating that the cell death is
downstream of activation of the cytosolic innate immune
sensing system5,7.
Current theory holds that ADAR1-deficient cells die
via apoptosis. The original evidence for this was
obtained by histological analysis (pyknotic nuclei, DNA
fragmentation) and immunohistochemical TUNEL
staining of Adar1−/− embryos at E11.0–E11.5 (refs. 3,4).
The same gross morphological phenotype was observed
in Adar1E861A/E861A embryos, which specifically lack the
RNA editing activity of ADAR1 (ref. 5), or in embryos
lacking the cytosolic ADAR1p150 isoform10. Sub-
sequent analysis of mice with a deletion of ADAR1 in
adult hematopoietic cells or B-cells demonstrated a
substantive increase in Annexin-V-positive cells in the
bone marrow11,12. In human cells, ADAR1 knockdown
or knockout has been reported to induce cell death and
apoptosis by Caspase-3/7 fluorometric assays, cleaved
PARP or cleaved caspase-3 western blot analysis fol-
lowing perturbation with either UV exposure or treat-
ment with interferon-β9,13.
To definitively establish if the intrinsic (or “mitochon-
drial”) apoptosis pathway is required for the death of
ADAR1-editing-deficient embryos, we intercrossed
Adar1E861A/E861A and Bak−/−Bax+/− mice to generate
triple mutant Adar1E861A/E861A Bak−/−Bax−/− animals.
BAK and BAX are the essential effectors of the intrinsic
apoptosis program. Upon activation, BAK and BAX oli-
gomerize in the mitochondrial outer membrane, causing
permeabilization and the release of apoptogenic factors14.
We observed no Adar1E861A/E861ABak−/−Bax−/− animals
at weaning from intercrosses of Adar1E861A/+
Bak−/−Bax+/− mice, a not unexpected result given the
perinatal lethality associated with double deficiency of
BAK and BAX15. We therefore examined embryos at
E13.5, the timepoint at which Adar1E861A/E861A embryos
become non-viable. From an analysis of 82 embryos
across 10 litters, we recovered 2 Adar1E861A/E861A
Bak−/−Bax−/−, compared to an expected 5 assuming
Mendelian inheritance (Fig. 1a). Surprisingly, loss of BAX
and BAK did not extend the survival of ADAR1-editing-
deficient embryos.
Adar1E861A/E861ABak−/−Bax−/− embryos were small, pale,
and exhibited signs of hemorrhage, similar to Adar1E861A/
E861ABak−/−Bax+/+ and Adar1E861A/E861ABak−/−Bax+/−
embryos (Fig. 1b). Given the well-described phenotype of
ADAR1-editing-deficient hematopoietic cells, and fetal livers
in particular, we focused analysis on this organ. We found
there was no modification of the Adar1E861A/E861A pheno-
type by concurrent deletion of BAK and BAX. The total
cellularity (Fig. 1c) and differentiation trajectory of erythroid
cells (Fig. 1d–g), the primary cell type in the fetal liver at this
developmental timepoint, were not changed. There was a
profound loss of cells—proportionally and in absolute
number—from all stages of erythroid differentiation in the
ADAR1-editing-deficient mutants, irrespective of the capa-
city to effect intrinsic apoptosis (Fig. 1f, g).
The genetic analysis demonstrates that the intrinsic
apoptosis pathway is not responsible for the death of
ADAR1-editing-deficient embryos. We had anticipated
that the loss of BAK and BAX would rescue, or at least
significantly extend, the gestational viability of
ADAR1E861A/E861A embryos. However, the triple mutant
Adar1E861A/E861ABak−/−Bax−/− embryos that were
recovered at E13.5 were indistinguishable from embryos
with wild-type BAK and BAX. In vivo the complete loss of
ADAR1 or the specific abolition of RNA editing by
ADAR1 are incompatible with embryonic development,
yet the present results demonstrate that this not the result
of utilization of the intrinsic apoptosis pathway. The
MDA5–MAVS axis is the primary in vivo sensor of
endogenous unedited RNA in both human and mouse
cells, activating a cascade that ultimately results in cell
death5,7,8. Several recent studies, principally from in vitro
tissue culture, have begun to illuminate pathways down-
stream of MAVS that may be important16–18. Most
directly addressing this, it was reported that RNaseL was
the downstream effector of cell death of cells engineered
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to be ADAR−/− based on rescue of the viability using
human A549 cells; however, the mechanism of cell death
was not clearly ascribed18. The ability of RNaseL knock-
out to rescue the murine ADAR1 deficiency has not been
formally reported to the best of our knowledge. Indirectly,
using transfection of the exogenous RNA agonists 5′tri-
phosphate RNA (RIG-I agonist) or poly(I):poly(C) (TLR-
3/MDA5 ligand), which signal via MAVS, it was demon-
strated that in murine macrophages these stimuli induced
TNF and IFNAR dependent necroptosis16. In vivo, the
loss of IFNAR (Ifnar−/−) or the compound loss of IFNAR
and IFNGR (Ifnar−/−Ifngr−/−) delayed to E15.5 the leth-
ality of the Adar1−/− embryos6,8. This suggested a role for
IFN signaling in accelerating the death of ADAR1-
deficient embryos, consistent with the in vitro studies16.
The combined loss of TNF and IFNAR signaling in vivo
has not been reported to date. A separate study has pro-
posed that transfection with poly(I):poly(C) induced
autophagy downstream of MAVS17. Recent evidence of
cleaved capsase-3 or PARP in human ADAR1 null or
knockdown cells has come in the context of additional
exogenous stimulation, such as UV exposure or treatment
with interferon-β9,13. Our studies reflect the cellular
response to a lack of ADAR1 mediated A-to-I editing in
the context of normal physiological development in vivo.
Collectively, the results from this study and those repor-
ted in the literature indicate that cell death following the
loss of ADAR1 is likely the result of the activation of
multiple pathways, including but not solely restricted to
the characteristic Type I interferon response. These
include necroptosis and forms of cell death associated
with inflammation19. The results indicate that cell death
processes not requiring the intrinsic apoptosis pathway
are triggered by MDA5 following the loss of A-to-I
editing.
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